Oxidative radioiodination of meclofenoxate as a preclinical brain imaging agent
Author:
El-Motaleb Abd El-Rhman Mohamed Abd1,
Ibrahim Ismail Taha1,
Abd El-Halim Sayed Mohamed1,
El-Tawoosy Mahmoud El-Sayed1
Affiliation:
1. Atomic Energy Authority, Cairo, Egypt
Abstract
Abstract
Meclofenoxate is a drug used to cause a broad improvement in brain function and mental performance. Meclofenoxate was successfully
labeled with 125I via direct electrophilic substitution reaction at room temperature. Percent radiochemical yield was
evaluated by paper electrophoresis and HPLC. The reaction parameters affecting the preparation process were studied in
details. 125I-meclofenoxate gave maximum percent radiochemical yield of about 95 ± 1.0% with specific activity
1.9 μCi/μg meclofenoxate and its stability was up to 4 h. Biodistribution studies showed that maximum
uptake of 125I-meclofenoxate in the brain of mice was 4.27 ± 0.3% injected dose (ID)/g tissue organ at
15 min post-injection. This uptake of 125I-meclofenoxate was found to be enough to image brain as it still
4.3% ID/g at 30 min post injection.
Publisher
Walter de Gruyter GmbH
Subject
Physical and Theoretical Chemistry